Although the comparison between 34 hr and 58 hr showed no differences in most metabolites except butyrates and OA, we also noticed that some metabolites peaked in 34 hr, while other metabolite kept increasing until 58 hr (cis-aconitate, succinate, nicotinamide (Fig
Phase 4 (Post-Marketing): Monitors long-term safety, effectiveness, and rare side effects after the drug reaches the market
Supports healthy skin cell turnover and surface clarity*
(2022) showed that Smad 2/3 and stratifin proteins play a detrimental role in CP-induced AKI by inducing necroptosis and necroinflammation, and interestingly, targeting these proteins suppressed the necroptosis signaling and thereby alleviating AKI
It serves as a potent antioxidant, anti-inflammatory agent, anti-aging solution, cellular detoxifier, and brain health enhancer